SHARK BYTES on MSN

Megalodon myth destroyed

Viral clips claim the Megalodon is still alive, but a real shark expert isn’t buying it. Watch as he breaks down the fake ...
The Real Housewives of Orange County After Show airs BravoTV.com and Peacock on Thursdays. As seen on Season 19, Episode 16, none of the women seemed to be on the same page about exactly how good of ...
It appears as though almost every national media member across this great country of ours believes Ohio State is the No. 1 team in the country, aside from USA TODAY's Paul Myerberg. To get a look at ...
I Did Nazi This Coming (JK We All Did): Trump wanted Paul Igrassia to lead the Office of Special Counsel, but Igrassia had to withdraw himself from consideration after Politico uncovered racist texts ...
"When I see his name to this day in the prompter, my heartbeat starts to go," the 'Today' host admits. Mekishana Pierre is a news writer at Entertainment Weekly. She has been working at EW since 2025.
If the Mets want to be the best, they have to beat the best. Professional sports leagues are all copycat leagues, meaning teams copy one another in hopes of replicating success in certain areas, or ...
LAKEWOOD, Colorado — The second victim from the school shooting at Evergreen High School was released from a hospital in Lakewood on Tuesday, the Jefferson County Sheriff's Office said. Matthew ...
The government shutdown has delayed the Bureau of Labor Statistics’ jobs report, but private data suggests the market remains challenging, though there are a few bright spots for job seekers. In the ...
The IRS really means it this time when they say that high earners will have to start paying tax soon on their catch-up 401(k) contributions and then deposit them into workplace Roth accounts. Sort of.
In a shelter in Brighton, England, one dog is still waiting after more than 1,407 days in a shelter. Almost four years after he arrived, Cane Corso Ralph is estimated to be between 4 and 5 years old, ...
Nektar Therapeutics' leading candidate is performing well so far in phase 2 studies. This medicine could disrupt the large and competitive eczema treatment market. Nektar could match Wall Street's ...